Compare BioNano Genomics Inc (BNGO) vs Ishares Msci Brazil ETF (EWZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Ishares Msci Brazil ETF — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.66M), while Ishares Msci Brazil ETF trades at $33.78. The key difference: Ishares Msci Brazil ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | EWZ | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $4.92 | $41.75 |
52-Week Low | $1.06 | $27.36 |
Enterprise Value | $16.26M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
EWZ, the iShares MSCI Brazil ETF, trades at $33.86, down 3.78% in the last session. Technical indicators are bearish overall, with moving averages signaling sell pressure, though oscillators suggest potential for a near-term bounce. Recent news highlights institutional interest, with Empowered Funds LLC taking a $3.06 million position as of August 5, 2026, and Allspring Global Investments increasing its stake significantly in July 2026. The fund offers exposure to Brazilian equities, with a dividend announced for June 2026.
The outlook for EWZ hinges on Brazil's economic trajectory, particularly interest rate cuts and commodity prices. Opportunities exist for value-seeking investors given Brazil's market potential, but risks include U.S. tariff impacts (Reuters, July 16, 2026) and competition from lower-cost ETFs like FLBR, which offers a higher dividend yield (Seeking Alpha, July 16, 2026).
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Ishares Msci Brazil ETF
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →
